Á lódáil...
Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization
Ocular neovascular diseases like wet age-related macular degeneration are a major cause of blindness. Novel therapies are greatly needed for these diseases. One appealing antiangiogenic target is reduction-oxidation factor 1–apurinic/apyrimidinic endonuclease 1 (Ref-1/APE1). This protein can act as...
Na minha lista:
| Foilsithe in: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
The American Society for Pharmacology and Experimental Therapeutics
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7250474/ https://ncbi.nlm.nih.gov/pubmed/30076264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.118.248088 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|